Skip to main content
. 2024 Apr 26;11:20499361241248058. doi: 10.1177/20499361241248058

Figure 3.

Figure 3.

Drug susceptibility of ESBL and non-ESBL. (a) Ampicillin, (b) aztreonam, (c) ciprofloxacin, (d) cefoperazone/sulbactam, (e) ceftriaxone, (f) cefotaxime, (g) cefuroxime, (h) cefazolin, (i) ertapenem, (j) levofloxacin, (k) meropenem, and (l) piperacillin.

ESBL, extended-spectrum β-lactamase.